Vial Sealing Applications by Drug Product Type

The right vial seal depends on the drug product inside: a multidose vaccine, a high-value biologic, a lyophilised cake and a cytotoxic oncology fill each place different demands on the closure, from container closure integrity and tamper evidence to cold-chain robustness and machinability. This hub maps the main pharmaceutical applications to the closure considerations that matter for each, and to the Autofits seal that fits.

This page is for formulators, packaging engineers and sourcing managers choosing a vial closure by application. It gives an overview of how seal selection changes with the product, a mapping table you can scan, and links to the detailed application pages.

Key takeaways

Vial seal selection is application-led. The same 20 mm flip-off seal that suits a routine injectable may not be the best fit for a lyophilised biologic or a multidose vaccine.
The recurring decisions are container closure integrity (CCI), tamper evidence, machinability on the capping line, sterility and form of supply, and, where relevant, lyophilisation and cold-chain robustness.
For most injectable applications the FlipTop® Optima flip-off seal is the default; specific applications point to the Pull-Ring or Tear-Down designs.
Closure standards run across all of these: ISO 8362-6 (aluminium-plastics caps), ISO 15378 (GMP for primary packaging), USP <1207> (CCI) and EU GMP Annex 1.
Detailed pages exist for vaccines and biologics; lyophilised products and oncology are expanding, with ophthalmic, diagnostic and veterinary to follow.

How vial-seal selection varies by application

Every injectable vial closure does the same core job: an aluminium shell crimps under the vial neck flange, compressing the rubber stopper against the glass to form the sterile barrier. What changes from one application to the next is the set of secondary requirements layered on top of that barrier.

A multidose vaccine needs a closure the user can open quickly and identify by colour, plus tamper evidence so a punctured or opened vial is obvious. A biologic is high in value and sensitive to extractables and leachables, so the priority shifts to material compliance and demonstrable container closure integrity across the shelf life. A lyophilised product is capped after freeze-drying, often with the stopper part-seated in the lyophiliser, so machinability and a clean crimp on a partially inserted stopper matter most. A cytotoxic oncology fill demands a robust, well-defined tamper-evident seal because any breach has occupational-safety consequences as well as sterility ones.

The mechanics also differ. Most applications want a flip-off button that exposes only a small injection point while the aluminium stays crimped. Some, such as oral vaccinations or products where the whole seal must come off for full access, call for a tear-down or pull-ring design instead. Cold-chain products add a further constraint: the closure system has to keep its seal through freezing and thawing without the crimp loosening.

The table below summarises these patterns and points to the Autofits closure that fits each application.

Application to closure mapping

Application	Key closure considerations	Suggested Autofits closure
Vaccines	Multidose vs single-dose access, fast opening, colour coding, tamper evidence, cold chain; oral vaccinations need full removal	FlipTop® Optima flip-off (13/20 mm); Tear-Down for oral vaccines
Biologics	Extractables and leachables, demonstrable CCI, high-value fill, material compliance over shelf life	FlipTop® Optima and Pull-Ring (13/20 mm)
Lyophilised products	Capping on a part-seated stopper, clean crimp, machinability, CCI on the freeze-dried cake (expanding)	FlipTop® Optima (13/20 mm)
Oncology / cytotoxic	Robust tamper evidence, occupational-safety driven CCI, secure single-dose closure (expanding)	FlipTop® Optima Button design (13/20 mm)
Ophthalmic	Small-volume single-dose vials, sterility, fine dimensional control (expanding)	FlipTop® Optima (13 mm)
Diagnostics / reagents	Lower regulatory burden, sometimes full stopper access, cost-led (expanding)	Tear-off seals and FlipTop® Optima
Veterinary	Multidose use, robust handling, oral dosing in some lines (expanding)	FlipTop® Optima and Tear-Down

Pages marked “expanding” are being built out; the closure suggestions reflect current Autofits practice. Browse closures by neck size from the by-size index, and see the full range on the products page.

A note on standards

Whatever the application, the same closure standards apply. Autofits aluminium-plastic seals are designed to ISO 8362-6, the standard for caps made of aluminium-plastics combinations for injection vials, with vial necks following ISO 8362-1. All-aluminium seals relate to ISO 8362-3. Production runs under ISO 15378:2017, the GMP standard for primary packaging materials. For the sterile barrier itself, container closure integrity is evaluated against USP <1207>, and aseptic-filling expectations, including the CCI requirement for sterile products, are set by EU GMP Annex 1. These cut across every application below; the application pages note only where a standard carries extra weight for that product type.

FAQ

Why does the drug product affect which vial seal I choose?

The seal always forms the sterile barrier the same way, by crimping the aluminium shell to compress the stopper. The product determines the secondary requirements: a multidose vaccine needs fast opening and tamper evidence, a biologic needs material compliance and proven container closure integrity, a lyophilised product needs a clean crimp on a part-seated stopper. Matching those requirements is what application-led selection means.

What is the default closure for most injectable applications?

For most liquid and lyophilised injectables the FlipTop® Optima flip-off seal in 13 mm or 20 mm is the default. You flip the plastic button to expose a central injection point while the aluminium stays crimped. Specific applications, such as oral vaccinations or products needing full stopper removal, point to the Tear-Down or Pull-Ring designs instead.

Which seal sizes are most common?

The 20 mm neck is the highest-volume size for injectable vials, and 13 mm is common for smaller-volume products such as some vaccines, biologics and ophthalmics. Larger parenterals, diluents and infusion-style vials use 28, 32 and 34 mm. Match the seal to the vial finish and the stopper of the same nominal diameter.

Do all these applications use the same standards?

Yes, broadly. ISO 8362-6 governs the aluminium-plastic cap design, ISO 15378 governs the GMP quality system, and USP <1207> with EU GMP Annex 1 cover container closure integrity and aseptic expectations. The application pages call out where one of these matters most for a given product.

Where can I see closures for a specific application?

Detailed pages exist for vaccines and biologics. Lyophilised products and oncology are being built out, with ophthalmic, diagnostic and veterinary to follow. For a closure-first view, start from the products page or the by-size index.

Sources

Autofits FlipTop Seals dossier and engineering drawings (working/spec-sheets/)
ISO: ISO 8362-6:2010, Injection containers and accessories, Part 6: Caps made of aluminium-plastics combinations for injection vials (https://www.iso.org/standard/45641.html)
ISO: ISO 15378:2017, Primary packaging materials for medicinal products, GMP requirements (https://www.iso.org/standard/70845.html)
USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)
EudraLex Volume 4, EU GMP Annex 1, Manufacture of Sterile Medicinal Products (https://health.ec.europa.eu/)

*Last updated: 2026-06-27. This page is general technical information, not regulatory or compliance advice; confirm current standard editions and your own specification with Autofits and the issuing bodies.*